Stock Scout

[Stock Scout @ScoutStock]

Gr-md-02

[Stock Scout @ScoutStock]

Belapectin

[Stock Scout @ScoutStock]

$galt

[Savage Minds @SavageMindsMag]

Jay Lalezari, MD discusses the drug leronlimab which demonstrates a 82% reduction in the rate of death at Day 14 for COVID-19 patients on a ventilator, stressing the urgency for FDA approval of this drug under the EUA. #COVID #FDA #pharma @SavageMindsMag
https://t.co/JoG5tJaOFT

[Stock Scout @ScoutStock]

@ABCPolitics @MarthaRaddatz Further efforts to draw attention to therapeutic #leronlimab the FDA has insisted on additional trials on a compound that ALREADY has been used safely with patients stricken with the AIDS virus, why the delays? @CytoDyn @US_FDA @Surgeon_General

[Savage Minds @SavageMindsMag]

Jay Lalezari, MD discusses the drug leronlimab which demonstrates a 82% reduction in the rate of death at Day 14 for COVID-19 patients on a ventilator, stressing the urgency for FDA approval of this drug under the EUA. #COVID #FDA #pharma @SavageMindsMag
https://t.co/JoG5tJaOFT

[Stock Scout @ScoutStock]

@ABCPolitics @MarthaRaddatz Dr. Murthy touts the large number of therapeutics, but some like monoclonal antibody Leronlimab from @CytoDyn still get slow walked by the #FDA even w/an excellent safety profile! This CCR5 antagonist may tame the #cytokinestorm but delays are keeping it from those that need it

[Stock Scout @ScoutStock]

$galt

[Stock Scout @ScoutStock]

Belapectin

[Stock Scout @ScoutStock]

Grmd02

[Donna @Anonymous_0004]

Two prominent Physician’s urge the FDA to issue an EUA for ⁦@CytoDyn⁩’s #leronlimab now while confirmatory studies are completed. There is no other SOC to treat severe/critical COVID-19 patients. ⁦@US_FDA⁩ ⁦@DrWoodcockFDA⁩ ⁦⁦@AP⁩ https://t.co/WtWAZah3PQ

[Pandemicene-Weary MD 🍉 @pandemicwearymd]

In a recent randomized control trial, #leronlimab showed a 82% reduction in mortality in critically ill patients by day 14, after two doses of the drug (given once weekly as a subQ shot). https://t.co/PbDfg0ralj

[Pandemicene-Weary MD 🍉 @pandemicwearymd]

#Leronlimab’s mechanism of action in COVID-19 has been described in this landmark paper by Dr. Bruce Patterson. https://t.co/WRmFNeiv5H. He also spoke about his findings in this video https://t.co/T23KtlbBJz @gunj80

[Pandemicene-Weary MD 🍉 @pandemicwearymd]

'We Are Pressured To Prescribe Drugs That Don't Work' https://t.co/zHuntojp7d These Indian physicians agree that we need to treat COVID aggressively at the immunologic phase, #leronlimab is one such therapeutic shown to calm cytokine storm, augment cell-mediated response @gunj80

[Stock Scout @ScoutStock]

@sakshi_dayal @IndianExpress @CytoDyn Here is a link where Harish Seethamraju, MD of Mount Sinai School of Medicine explains the impressive results of #Leronlimab from @CytoDyn, #India needs to get this CCR5 antagonist to alleviate suffering

https://t.co/XMirb3D0VU

[Stock Scout @ScoutStock]

@sakshi_dayal @IndianExpress I urge you to look into #Leronlimab from @CytoDyn, which was recently administered to former Philippines President who was in ICU

https://t.co/pzwGposcCu

[marsplanet @sunshine43223]

#IndiaFightsCOVID19 #IndiaNeedsOxygen india get #leronlimab to fix oxygen problems.

[Donna @Anonymous_0004]

@DrWoodcockFDA @US_FDA the world is waiting for your EUA of @CytoDyn’s #Leronlimab. With proven efficacy and safety, COVID-19 lives deserve a chance to LIVE. It reduced deaths by 82% at day 14 in the critical pop. NO SAEs. People around the world are dying, they need this drug.

[Bulkley Janeen @janemdiago]

#Leronlimab Saving Lives Now in the Philippines .... what Country is next ?

[Stock Scout @ScoutStock]

@janemdiago India needs Leronlimab

[Bulkley Janeen @janemdiago]

So Heartbreaking , get them #Leronlimab ASAP! India needs Leronlimab to help Save Lives ! @DrWoodcockFDA and USA PLEASE !